CRVO - CIK 0001053691
CervoMed Inc. (CRVO) reported net income of -$26.97M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$26.97M | -65.6% |
| FY 2024 | -$16.29M | -650.7% |
| FY 2023 | -$2.17M | +62.6% |
| FY 2022 | -$5.80M | +75.9% |
| FY 2021 | -$24.10M | -69.9% |
| FY 2020 | -$14.19M | -20.2% |
| FY 2019 | -$11.80M | +35.8% |
| FY 2018 | -$18.37M | -1246.2% |
| FY 2017 |
CervoMed Inc. (CRVO) reported net income of -$26.97M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, CervoMed Inc.'s net income declined from -$22.64M to -$26.97M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$1.36M |
| +92.4% |
| FY 2016 | -$18.04M | -168.4% |
| FY 2015 | -$6.72M | +53.2% |
| FY 2014 | -$14.35M | -483.9% |
| FY 2013 | -$2.46M | +64.2% |
| FY 2012 | -$6.87M | +69.7% |
| FY 2011 | -$22.64M | - |